T.MAN Pharmaceutical PCL (BKK:TMAN) Payments of Debt: ฿-82 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:TMAN T.MAN Pharmaceutical PCL BKK:TMAN
21 GF Score
Price ฿10.70
View Full Analysis

What is T.MAN Pharmaceutical PCL Payments of Debt?

T.MAN Pharmaceutical PCL BKK:TMAN -0.93% 21 Payments of Debt is ฿-82 Mil as of Jun. 2026. GuruFocus rates BKK:TMAN with a GF Score™ of 21/100.

T.MAN Pharmaceutical PCL's Payments of Debt for the three months ended in Jun. 2026 was ฿18 Mil.

T.MAN Pharmaceutical PCL's Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2026 was ฿-82 Mil.

T.MAN Pharmaceutical PCL Payments of Debt Related Terms

T.MAN Pharmaceutical PCL Payments of Debt Historical Data

* Premium members only.

The historical data trend for T.MAN Pharmaceutical PCL's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

T.MAN Pharmaceutical PCL Payments of Debt Chart

T.MAN Pharmaceutical PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Payments of Debt
-102.37 -93.20 -393.06 -212.28

T.MAN Pharmaceutical PCL Quarterly Data
Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -71.42 -57.73 -16.57 -26.54 18.47
BKK:TMAN
21GF Score
T.MAN Pharmaceutical PCL BKK:TMAN
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

T.MAN Pharmaceutical PCL Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of ฿-82 Mil mean?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a Payments of Debt of ฿-82 Mil as of Jun. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on T.MAN Pharmaceutical PCL and its competitors.
Is T.MAN Pharmaceutical PCL's Payments of Debt too high?
T.MAN Pharmaceutical PCL's current Payments of Debt is ฿-82 Mil. Overall, T.MAN Pharmaceutical PCL has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does T.MAN Pharmaceutical PCL's Payments of Debt compare to ZTS and UTHR?
T.MAN Pharmaceutical PCL's Payments of Debt of ฿-82 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Drug Manufacturers company?
A good Payments of Debt depends on the Drug Manufacturers industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on T.MAN Pharmaceutical PCL and its competitors. T.MAN Pharmaceutical PCL's current Payments of Debt is ฿-82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T.MAN Pharmaceutical PCL stock overvalued right now?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a current Payments of Debt of ฿-82 Mil. The current Payments of Debt is ฿-82 Mil. T.MAN Pharmaceutical PCL's overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For T.MAN Pharmaceutical PCL (BKK:TMAN), the current Payments of Debt is ฿-82 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

T.MAN Pharmaceutical PCL Business Description

Address Bangkhunthian Road, 69/1 Soi Bangkhunthian 14, Samaedum Subdistrict, Bangkhunthian District, Bangkok, THA, 10150
T.MAN Pharmaceutical PCL is engaged in purchasing, importing, manufacturing, and distributing original equipment and in manufacturing, distributing, and exporting modern medicines, traditional medicines, dietary supplements, and healthcare products for the healthcare industry. It offers products through brands such as T.Nutrition, T.Derma, Mommy&Me, TMT, Heaven Herb, and T.Pharmaceutical. The company's reportable segments are: Segment for manufactured products under own brand, which derives key revenue, Segment for manufactured products under third parties' brand, and Segment for trading products.
21GF Score

Get the complete analysis for BKK:TMAN

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿10.70
Price